0001209191-18-005804.txt : 20180129
0001209191-18-005804.hdr.sgml : 20180129
20180129153125
ACCESSION NUMBER: 0001209191-18-005804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180125
FILED AS OF DATE: 20180129
DATE AS OF CHANGE: 20180129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bell Graeme
CENTRAL INDEX KEY: 0001643757
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 18555295
MAIL ADDRESS:
STREET 1: 1324 WAVERLY ROAD
CITY: GLADWYNE
STATE: PA
ZIP: 19035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-25
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001643757
Bell Graeme
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET, SUITE 130
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Chief Financial Officer
Stock Option (right to buy)
22.78
2018-01-25
4
A
0
25000
0.00
A
2028-01-24
Common Stock
25000
25000
D
This option was granted on January 25, 2018 with respect to 25,000 shares of Common Stock, with 25% vesting on January 25, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
/s/Jose Rivera, Attorney-In-Fact
2018-01-29